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Ecto-nucleotidases play a pivotal role in terminating the signalling via ATP and in producing
adenosine, a neuromodulator in the nervous system. We have now investigated the pattern of
adenosine formation with different concentrations of extracellular ATP in rat hippocampal
nerve terminals. It was found that adenosine formation is delayed with increasing concentra-
tions of ATP. Also, the rate of adenosine formation increased sharply when the extracellular
concentrations of ATP 1 ADP decrease below 5 mM, indicating that ATP/ADP feed-forwardly
inhibit ecto-58-nucleotidase allowing a burst-like formation of adenosine possibly designed to
activate facilitatory A2A receptors. Initial rate measurements of ecto-58-nucleotidase in hip-
pocampal nerve terminals, using IMP as substrate, showed that ATP and ADP are competitive
inhibitors (apparent Ki of 14 and 4 mM). In contrast, in hippocampal immunopurified choliner-
gic nerve terminals, a burst-like formation of adenosine is not apparent, suggesting that chan-
nelling processes may overcome the feed-forward inhibition of ecto-58-nucleotidase, thus
favouring A1 receptor activation.
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manner (5,6). ATP can also be released from the stim-
ulated post-synaptic component (7), from glial cells (8)
and upon mechanical stimulation of various cell types
(e.g. 9,10). Once released, ATP can act as neurotrans-
mitter via activation of ionotropic P2X receptors, as
now established in the sympathetic and also in some
parasympathetic systems (1). However, in the central
nervous system, ATP has only been shown to act as a
neurotransmitter in a few synapses (11). Instead, or in
parallel, ATP can also act as a presynaptic modulator
(12) and be involved in neuron-glia signalling (13) via
either P2X or metabotropic P2Y receptors.
In contrast to the versatile role proposed for ATP in
the nervous system, adenosine fulfils a neuromodulatory
role. Adenosine can also be released as such through
bi-directional non-concentrative adenosine transporters
from nerve terminals, activated postsynaptic compo-
nents or from glial cells (14). Adenosine mostly modu-
lates synaptic transmission acting presynaptically to
INTRODUCTION
Purines are well recognised as part of the chemical
arsenal used in transmission and fine-tuning of trans-
mission in the nervous system (1). There are two major
players in this family: ATP and adenosine, the former
being converted into the latter by an ecto-nucleotidase
pathway that plays a critical ‘go-between’ role.
ATP is stored together with neurotransmitters in
synaptic vesicles (reviewed in 2) and is released in
a quantal (3), vesicular (4) and frequency-dependent
control neurotransmitter release (14). Adenosine also
acts postsynaptically to hyperpolarise neuronal mem-
brane potential (15), tightly controlling the functioning
(e.g. 16) and rate of desensitisation of ionotropic re-
ceptors to excitatory neurotransmitters (17). Until a few
years ago, it was commonly thought that adenosine was
mainly an inhibitory neuromodulator, but it is now clear
that the effects of adenosine, at least in relation to the
control of neurotransmitter release, depend on the bal-
anced activation of inhibitory A1 receptors and of facil-
itatory A2A receptors (14). The generally recognised role
of A1 receptor-mediated inhibition in the central nervous
system mostly results from the greater density of A1
receptors in the nervous system and to the experimental
conditions generally used that favour the release of
adenosine as such mostly from non-synaptic sources
and that do not favour A2A receptor function (discussed
in 14,18). It has recently been proposed that one way
for extracellular adenosine to preferentially activate
either inhibitory or facilitatory receptors would depend
on the manner in which extracellular adenosine was
generated: release of adenosine as such through bi-
directional non-concentrative adenosine transporters
would favour A1 receptor-mediated inhibition whereas
formation of adenosine from the extracellular cata-
bolism of ATP would favour A2A receptor-mediated
facilitation (14,19,20).
According to this proposal, the ecto-nucleotidase
pathway would not only be designed to remove a re-
leased signalling molecule (ATP) but also to produce
in a highly controlled manner another messenger mol-
ecule (adenosine) and contribute to purine salvage (21).
The importance of ATP catabolism is strengthen by
the numerous enzymatic activities that can fulfil this
function either from the E-NTPase family (including
the ‘ecto-ATPase’ and ‘ecto-ATP diphosphohydrolase’)
and the ecto-phosphodiesterase/nucleotide pyrophos-
phatase (E-PNPP) family (22). At this stage, the lack
of clear kinetic hallmarks and of pharmacological
tools makes it difficult to identify in situ the molecu-
lar entities responsible for ATP catabolism, in partic-
ular because several of them appear to be co-expressed
and co-located in the same cells (e.g. 23). Also, the
lack of potent and selective inhibitors of extracellular
ATP catabolism, makes it difficult to assess the func-
tional role of ecto-ATPases in removing extracellular
ATP [I will use the old terminology of ecto-ATPase to
refer to any possible(s) molecular entity(ies) involved
in extracellular ATP catabolism from now on].
Functionally, the ecto-nucleotidase pathway has
mostly been related to its ability to form extracellular
adenosine involved in the modulation of neurotransmit-
ter release (14). In this respect, this pathway potentially
allows to relate the amounts of released ATP to the ac-
tivation of different adenosine receptors, based on the
feed-forward activation of ecto-58-nucleotidase (the en-
zyme that converts AMP into adenosine) by ATP and/or
ADP. Thus, when the transient amounts of released ATP
are high, AMP will have to accumulate due to the feed-
forward inhibition of ecto-58-nucleotidase and only
when the levels of ATP and/or ADP decrease below the
threshold level of inhibition of ecto-58-nucleotidase will
adenosine be formed in high transient amounts, possibly
enough to trigger A2A receptor-mediated facilitation
(discussed in 14,18). This kinetic pattern has experi-
mentally been verified in striatal nerve terminals (24)
and is in agreement with the ability of a,b-methylene
ADP, a competitive ecto-58-nucleotidase inhibitor (25),
to relieve a tonic A2A receptor-mediated facilitation of
neurotransmitter release (19,26). Indeed, the presence
of a,b-methylene ADP causes a decreased formation of
synaptically released adenosine (5,20,27,28). However,
in some preparations, it was concluded that the presence
of a,b-methylene ADP instead blunts inhibitory A1
receptor activation (29–32). This may either be due to a
lower release of ATP, that would only reach concentra-
tions below the threshold of inhibition of ecto-58-
nucleotidase or to the existence of kinetic restrains
of the activity of the ecto-nucleotidase pathway, like
channelling processes (33,34), that would force a pref-
erential activation of inhibitory A1 receptors, in spite
of a feed-forward inhibition of ecto-58-nucleotidase
(discussed in 33).
In this work, the kinetic pattern of ATP catabo-
lism and adenosine formation in hippocampal nerve
terminals was compared at different concentrations of
ATP to try to estimate the threshold of inhibition of
ecto-58-nucleotidase by ATP and/or ADP. The kinetic
parameters of ecto-58-nucleotidase inhibition by ATP
and ADP were then directly studied by carrying out
initial rate measurements of ecto-58-nucleotidase ac-
tivity. Finally, the relevance of this feed-forward inhi-
bition of ecto-58-nucleotidase activity by ATP and
ADP was investigated in hippocampal immunopuri-
fied cholinergic nerve terminals, where adenosine gen-
erated from the ecto-nucleotidase pathway activates
A1 receptors (32).
EXPERIMENTAL PROCEDURE
Preparation of Hippocampal Nerve Terminals. Hippocampal
nerve terminals were prepared from male Wistar rats (6–9 weeks old)
by a sucrose/Percoll purification method, as previously described (35).
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When using hippocampal cholinergic nerve terminals, they were ob-
tained by immunopurification from the Percoll purified nerve terminals
using a goat anti-Chol1 anti-serum and rat IgG anti-goat monoclonal
antibodies covalently coupled to a cellulose matrix (see 35,36).
Time Course Kinetic Experiments. Synaptosomes were resus-
pended and equilibrated at 37°C in 1 ml of Krebs/HEPES solution
of the following composition (mM): NaCl 124, KCl 3, NaH2PO4
1.25, MgSO4 1, CaCl2 2, HEPES 26, glucose 10, pH 7.4. Aliquots
of 100 ml were added to incubation vials with 600 ml of Krebs/
HEPES solution and kept at 37°C. After 10 min incubation, the ini-
tial substrate, i.e. ATP (1–300 mM) was added. The kinetic proto-
cols consisted of a 60 min incubation period with sample collection
(50 ml) at 0, 1, 2.5, 5, 10, 15, 30, 45 and 60 min. The zero time
was defined as the sample collected immediately after (approxi-
mately 5 s) addition of the initial substrate. Each collected sample
was centrifuged (14,000 g for 10 s) and the supernatant (40 ml) was
ice-stored for HPLC analysis (37). After the 60 min incubation, the
synaptosomes were pelleted by centrifugation (14,000 g for 10 s).
The medium was used to estimate if there was any released ecto-
nucleotidase activity (exo-nucleotidases, see 22) and to quantify lac-
tate dehydrogenase activity, an index of cellular disruption, which
was always lower than 3% of total lactate dehydrogenase activity in
the synaptosomes. The pelleted synaptosomes were homogenized in
200 ml of 2% (v/v) Triton X-100 to determine total lactate dehydro-
genase activity and protein content (34,35).
The areas of the peaks obtained in the HPLC chromatograms
were converted into concentrations using calibration curves for each
substance (37). The concentrations of products in samples collected
from the same batch of nerve terminals incubated without adding
substrate (ATP) were subtracted for correction of spontaneous re-
lease. Plots of concentration of the substrate and products as func-
tion of time (progress curves) were constructed. Each progress curve
was analysed by the following parameters: half-degradation time of
the initial substrate; time of appearance of the maximum concentra-
tion of the first product; and concentration of substrate or any prod-
uct remaining at the end of the experiment. These parameters were
calculated as previously described (35) by fitting each curve with
a third degree polynomium using the Raphson-Newton method.
Unless otherwise stated, all values are presented as means 6 SEM
obtained in n experiments.
Initial Rate Measurement of Ecto-59-Nucleotidase. Synapto-
somes were resuspended and equilibrated at 37°C in 1 ml of
Krebs/HEPES solution and aliquots of 10 ml were added to incu-
bation vials with 590 ml of Krebs/HEPES solution and kept at
37°C. After 10 min incubation, the initial substrate, either AMP
(1–300 mM) or IMP (1–300 mM), was added without or with the
tested inhibitor ATP or ADP (1–100 mM). Samples (50 ml) were col-
lected from the bath at 0, 0.5, 1 and 1.5 min. Each collected sample
was centrifuged (14,000 g for 10 s) and the supernatant (40 ml) was
ice-stored for HPLC analysis (37). After the 1.5 min incubation, the
synaptosomes were pelleted by centrifugation (14,000 g for 10 s)
and homogenized in 200 ml of 2% (v/v) Triton X-100 to determine
the protein content (34,35). The areas of the AMP or IMP peaks
obtained in the HPLC chromatograms were converted into concen-
tration (37) and the initial rate of AMP or IMP catabolism was cal-
culated upon linear regression of the decrease in the concentration
of AMP or IMP with time. When studying the initial rate of extra-
cellular catabolism of ATP and ADP, the experimental protocols
were identical except that the initially added substrate was either
ATP (1 mM–3 mM) or ADP (1–300 mM).
The apparent kinetic parameters (KM and V ) of ecto-59-
nucleotidase (measured as the extracellular catabolism of AMP or
IMP) were obtained by non-linear fitting of the variation of the
initial rate with the concentration of AMP or IMP to the logistic
Henri-Michaelis-Menten equation. The apparent Ki of ATP and
ADP inhibition of ecto-58-nucleotidase activity were estimated with
the use of a Dixon plot (38) and the type of inhibition assessed with
a Cornish-Bowden plot (39).
RESULTS AND DISCUSSION
Extracellular ATP Catabolism in Hippocampal
Nerve Terminals. Time course kinetic studies have the
advantage of providing a general overview of the
change in concentration of several pathway-related
metabolites over time. But they have as a major dis-
advantage the difficulty in normalising results in
between experiments, specially when intact cells or
sub-cellular components are used, as is the case with
the presently described studies in nerve terminals. Nor-
malization by the amount of protein used is the only
possible strategy of normalisation but different amount
of nerve terminals will influence both the absolute
amount of purine metabolites and the time-course of
the appearance of their maximal concentrations. Thus,
it was decided to present individual experiments that
are considered representative of a series of experiments
performed with different batches of nerve terminals
prepared from different animals, as well as average
parameter values.
Fig. 1 illustrates the time-dependent changes in
the concentration of ATP, ADP, AMP and adenosine
after addition at zero time of different concentrations of
ATP (3–100 mM) to the same population of nerve ter-
minals. The first conclusion to be drawn from these ex-
periments is that the rate of extracellular catabolism of
ATP is rapid for any of the tested concentrations of
ATP with the amount of nerve terminals in these as-
says. The efficiency of the extracellular catabolism of
ATP is so intense that, in the first time point collected
between 5–10s after adding ATP, there is a marked de-
crease in the concentration of ATP with a concomitant
formation of ADP and AMP. This is due to an efficient
catabolism by the hippocampal nerve terminals since
the initial concentration as well as the purity of ATP
solutions added to the nerve terminals was always
confirmed by HPLC and the total amounts of ADP 1
AMP 1 adenosine present in these solution was always
less than 1.6% of the concentration of ATP.
An attempt was made to estimate the apparent ki-
netic parameters of extracellular ATP catabolism using
a 10 times lower amount of nerve terminals. The rapid
initial rate of catabolism was still observed in these
conditions and this lead to an apparent KM value of
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extracellular catabolism between 400–1200 mM, con-
siderably higher than what is found in most systems
(reviewed in 40). High KM values of extracellular ATP
catabolism were also found in rat ventricular myocytes,
in pig arterial smooth muscle cells and in pig aorta en-
dothelial cells and were justified by the hypothesis that
the depletion of substrate at the cell surface is rate lim-
iting for hydrolysis of ATP supplied from the bulk
phase (41–43). Interestingly, ecto-ATPase was found
to be located in caveolae (44), supporting the possible
occurrence of channelling processes.
One issue that can only marginally be addressed
with this type of studies is on the molecular entity re-
sponsible for the extracellular catabolism of ATP.
Some authors favour the view that there are two main
different entities, an ecto-ATPase and an ecto-ADPase
(24,41–43) whereas others champion the idea that the
extracellular catabolism of ATP and ADP are mainly
due to an ecto-ATP diphosphohydrolase (45–47). The
observed accumulation of ADP upon ATP catabolism
(Fig. 1) is strongly suggestive of a main ‘ecto-ATPase’
activity with higher catalytic efficiency than an ‘ecto-
ADPase’-like activity, rather than an ecto-ATP diphos-
phohydrolase activity. To further explore this issue, the
effect of b,g-imido ATP on the extracellular catabo-
lism of ATP and of ADP was tested. As illustrated in
Fig. 2, it was found that b,g-imido ATP (100 mM) in-
hibited more profoundly the extracellular catabolism of
ATP than that of ADP. Since b,g-imido ATP displayed
a competitive-like behaviour in relation to inhibition to
the extracellular catabolism of ATP (data not shown),
these data can only be taken as an indication favour-
ing the possibility that the major enzymatic activity
responsible for extracellular ATP catabolism in rat
hippocampal synaptosomes might be an ecto-ATPase
rather than an ecto-ATP diphosphohydrolase. It should
be added that besides E-NTPases, there should be
an ecto-nucleotide pyrophosphatase (E-PNPP) activity
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Fig. 1. Different time course kinetic pattern of ATP metabolism in rat hippocampal nerve terminals with different concentrations of
extracellularly added ATP. ATP (3 mM in A; 10 mM in B, 30 mM in C and 100 mM in D) was added at zero time to rat hippocampal nerve
terminals (696 mg protein) and samples were collected from the bath at the times indicated in the abscissa. Each collected sample was analysed
by HPLC to separate and quantify ATP (j) and its metabolites, ADP (d), AMP (.) and adesonine (s). The data were obtained from a single
experiment representative of 12 similar experiments.
present in hippocampal nerve terminals to understand
the previously reported conversion of b,g-substituted
ATP analogues into AMP, without a measurable for-
mation of extracellular ADP in rat hippocampal nerve
terminals (34). However, in the absence of selective in-
hibitors, it is not yet possible to estimate the relative
contribution of E-NTPases and E-PNPPases for extra-
cellular ATP catabolism.
The Ecto-Nucleotidase Pathway in Rat Hippocam-
pal Nerve Terminals. Fig. 1 also illustrates that there
was a qualitatively similar pattern of extracellular me-
tabolism of ATP into adenosine in hippocampal synap-
tosomes, with the different initial concentrations of
ATP tested (3–100 mM). The decrease in the extracel-
lular concentration of ATP was accompanied by an
increase in the extracellular concentration first of ADP
then of AMP and later of adenosine.
The formation of IMP was not detected in any ex-
periment, indicating that ecto-AMP deaminase activ-
ity is not present in rat hippocampal nerve terminals,
in contrast to what was reported in frog (48) and rat
neuromuscular junctions (49) where this pathway acts
as an adenosine shunt-like system to extracellularly
metabolise adenine nucleotides (27).
Also, the decrease in ATP is continuous over
time, indicating that a possible ecto-adenylate kinase
activity (see 50,51) or ecto-nucleoside diphosphoki-
nase activity (see 52), if present, do not appreciably
contribute for the extracellular ATP catabolism in rat
hippocampal nerve terminals, as observed in striatal
cholinergic nerve terminals (24).
Another issue carefully investigated was the pos-
sible activity-dependent release of exo-nucleotidases
that has been observed in different peripheral tissues
(10,53). After 60 min incubation of rat hippocampal
nerve terminals in the absence or in the presence of
ATP (30 mM), there was no measurable activity able
to metabolise ATP, ADP or AMP in the media after
centrifugation at 14,000 g (n 5 6). The same experi-
ments were also carried out in rat hippocampal nerve
terminals depolarised with 20 mM K1 for period rang-
ing from 2 min to 30 min (this period of incubation
with 20 mM K1 was not further extended, since a re-
lease of 10–15% of total lactate dehydrogenase al-
ready occurred after 30 min incubation). Again, under
these conditions, there was a lack of measurable exo-
nucleotidases (n 5 2–3 for each of the 5 tested condi-
tions). Thus, the release of exo-nucleotidases does not
appear to occur from hippocampal nerve terminals, al-
though it remains to be established if other synaptic
partners, like the post-synaptic component or glial
cells, may release exo-nucleotidases to the synapses in
the central nervous system.
Different Pattern of Adenosine Formation Accord-
ing to the Initial Concentration of ATP in Hippocampal
Nerve Terminals. In spite of being qualitatively similar,
the time course pattern of appearance of AMP and of
adenosine was different at different initial concen-
trations of ATP. Indeed, at low concentrations of ATP
(3 mM; Figure 1A), there was a low accumulation of
AMP (its peak extracellular concentration was 0.46 6
0.04 mM, n 5 16, i.e. nearly 15% of initially added
ATP). As the concentration of initially added ATP was
increased, the peak of AMP concentration was reached
later (3.1 6 0.7 min with 3 mM ATP, 4.8 6 0.6 min
with 10 mM ATP, 7.6 6 1.1 min with 30 mM ATP and
9.8 6 1.2 min with 100 mM ATP) and the maximal
amount of AMP was also percentually higher (37%
with 10 mM ATP, 51% with 30 mM ATP and 60% with
100 mM ATP) in the average of 12–18 experiments
similar to these illustrated in Fig. 1.
The pattern of appearance of extracellular adeno-
sine was also different with the different amounts of
initially added ATP. Indeed, when ATP (3 mM) was
used as initial substrate, the extracellular concentration
of adenosine rose immediately from time zero until
reaching a maximal concentration of 1.52 6 0.08 mM
after 2.9 6 0.2 min (n 5 16). However, as the concen-
tration of initially added ATP was increased, there was
an increasing time span before the concentration of
adenosine started to increase. Thus, with 10 mM ATP,
only after 2.5 min did the extracellular concentration of
adenosine start to increase; with 30 mM ATP it took
more than 10 min to see a change in the rate of extra-
cellular adenosine formation and this lag-time was in-
creased to more 15 min when 100 mM ATP was used
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Fig. 2. Inhibition by b,g-imido ATP of ATP and ADP extracellular
catabolism in rat hippocampal nerve terminals. ATP (10 mM; u,j)
or ADP (10 mM; s,d) was added at zero time to rat hippocampal
nerve terminals (62–104 mg protein) in the absence (open symbols)
or in the presence (filled symbols) of b,g-imido ATP (b,g-ImATP,
100 mM) and samples were collected from the bath at the times
indicated in the abscissa. Each collected sample was analysed by
ion-pair reverse-phase HPLC (Cunha et al., 1998) to quantify ATP
and ADP. The data are mean 6 sem of 5 experiments.
as initial substrate. This different lag time required to
see changes in the extracellular concentration of adeno-
sine is best illustrated by Fig. 3A that shows the change
in the relation of products and ‘substrates’ of ecto-58-
nucleotidase with time (see references 27 and 48 for
reasons to choose the ratio adenosine/ATP 1 ADP 1
AMP rather than adenosine/AMP to express ecto-58-
nucleatidase activity). The maximal concentration of
adenosine reached with the different concentrations of
ATP used as initial substrates was also percentually
higher as the concentration of ATP increased. Thus, the
maximal concentration of adenosine was 44% of ini-
tially added ATP with 3 mM ATP, it increased to 52%
with 10 mM ATP, to 62% with 30 mM ATP and was
not further increased (58%) with 100 mM ATP.
Although out of the scope of the present study,
this increased accumulation of adenosine with increas-
ing concentrations of ATP used as initial substrate is
also suggestive of the existence of an high affinity but
low capacity adenosine transport system. This does not
invalidate the present conclusions based on the analy-
sis of adenosine formation with different concentra-
tions of initially added ATP since the rate of formation
of adenosine from ecto-nucleotidases clearly over-
comes the rate of removal of extracellular adenosine,
as judged from the parallel lines shown in Fig. 3B.
Inhibition of Adenosine Formation with Increas-
ing Concentrations of ATP in Hippocampal Nerve
Terminals. One factor that may be responsible for this
different pattern of adenosine formation with different
concentrations of ATP used, is a feed-forward inhibi-
tion of ecto-58-nucleotidase by ATP and/or ADP (54).
To explore if there would be a threshold concentration
of ATP and ADP below which the rate of adenosine
formation would increase, the concentrations of ATP 1
ADP were determined at the time points before and
after the change in the rate of adenosine formation oc-
curred when using different concentrations of ATP as
initial substrate. From the data shown in Fig. 3B, it is
concluded that the concentration of ATP 1 ADP has
to decrease below an average value of 5 mM to allow
the bursting of extracellular adenosine formation.
Inhibition of Ecto-59-Nucleotidase Activity by ATP
and ADP in Hippocampal Nerve Terminals. In order to
confirm the threshold concentration of ATP and of ADP
above which ecto-59-nucleotidase inhibition occurs, we
conducted initial rate studies of ecto-58-nucleotidase in
rat hippocampal nerve terminals. Although there are ap-
parently several isoforms of ecto-58-nucleotidase re-
sponsible for the extracellular metabolism of AMP in
rat hippocampal nerve terminals as judged from im-
munological studies (55), it is assumed that they all rep-
resent an ecto-58-nucleotidase activity based on the
inhibition by a,b-methylene ADP (34,35), possibly the
only operational criteria to characterise an ecto-58-
nucleotidase activity (56). As shown in Fig. 4, AMP and
IMP are metabolised equally well by hippocampal
nerve terminals. The apparent kinetic parameters of
extracellular AMP catabolism yield an apparent KM
of 10.9 mM (95% confidence interval: 6.2–15.7 mM,
n 5 6) and an apparent V of 0.91 6 0.02 nmol/min/mg
protein (n 5 6) and these of extracellular IMP catab-
olism yield an apparent KM of 14.4 mM (95% confi-
dence interval: 8.6–20.2 mM, n 5 6) and an apparent
V of 0.93 6 0.07 nmol/min/mg protein (n 5 6). This
similarity in the pattern of catabolism of IMP and AMP
makes it reasonable to use IMP as a substrate to probe
the pattern of ecto-58-nucleotidase inhibition by ATP
and ADP. This overcomes the problem of changing the
substrate concentration when adding the inhibitors
(ATP or ADP), due to the fast catabolism of ATP and
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Fig. 3. Different pattern of ATP-derived adenosine formation with
different concentrations of initially added ATP. In panel A is plotted
the time-dependent change in the ratio of product/‘substrates’ of
ecto-58-nucleotidase during the time course kinetics of extracellular
ATP (3 mM as d; 10 mM as j; 30 mM as m; and 100 mM as l)
metabolism shown in Figure 1. Note that all the curves (except for
3 mM ATP) are biphasic, indicating that the rate of ATP-derived
adenosine formation increases at certain time points during
extracellular metabolism. In panel B are shown the concentrations
of ATP1ADP at the time points before and after the change in the
rate of ATP-derived adenosine formation shown in panel A. Note
that there is a marked and near constant change in the extracellular
concentration of ATP 1 ADP associated with the increase in the rate
of ATP-derived adenosine formation.
ADP in hippocampal nerve terminals. This rapid catab-
olism of ATP and ADP is also a problem for the deter-
mination of apparent inhibition constants, since the
effective concentration of ATP and ADP will decrease
sharply during the 1.5 min of the enzymatic assay. To
minimise this problem, the nerve terminals were diluted
10-fold in the initial rate assays.
Fig. 5 illustrates the pattern of inhibition by ATP
and ADP of extracellular IMP catabolism by rat hip-
pocampal nerve terminals. The Dixon’s plot illustrate in
Fig. 5A and 5B indicate that ADP is a slightly more po-
tent inhibitor of ecto-58-nucleotidase [Ki 5 4.3 mM
(95% confidence interval: 1.7–6.8 mM), n 5 5] than
ATP [Ki 5 14.1 mM (95% confidence interval:
7.8–20.5 mM), n 5 5]. The corresponding Cornish-
Bowden’s plots shown in Figures 5C and 5D indicate
that both ATP and ADP are competitive inhibitors of
ecto-58-nucleotidase in rat hippocampal nerve terminals,
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Fig. 4. Initial rate measurements of ecto-58-nucleotidase activity in
rat hippocampal nerve terminals using AMP (j, filled line) and IMP
(d, dashed line) as substrates. AMP or IMP (0.3–100 mM) was
added at zero time to rat hippocampal nerve terminals (47–78 mg
protein) and samples were collected from the bath at 0, 0.5, 1 and
1.5 min to measure by HPLC the rate of disappearance of AMP or
IMP. The data are mean6sem of 6 experiments and the average data
were adjusted by the Henri-Michaelis-Menten logistic equation.
Note that AMP and IMP yield a nearly superimposed kinetic profile.
Fig. 5. Inhibition by ATP and ADP of ecto-58-nucleotidase in rat hippocampal nerve terminals. IMP (1 mM as j; 3 mM as m; 10 mM as .;
30 mM as d; and 100 mM as l) was added at zero time to rat hippocampal nerve terminals (42–82 mg protein) in the absence or in the presence
of either ATP or ADP (1–100 mM) and samples were collected from the bath at 0, 0.5, 1 and 1.5 min to measure by HPLC the rate of
disappearance of IMP. Panels A and B show the Dixon’s plots of inhibition of ecto-58-nucleotidase by ATP (A) and ADP (B), indicating that
ADP is slightly more potent than ATP to inhibit ecto-58-nucleotidase. Panels C and D show Cornish-Bowden’s plots that suggest a competitive
pattern of inhibition of ecto-58-nucleotidase by both ATP and ADP. The results are mean of 6 experiments.
given that the regression lines are nearly parallel (39).
These findings are in agreement with these found for
Torpedo nerve terminals where a competitive inhibition
pattern by ATP and ADP of ecto-58-nucleotidase was
reported (57).
It should be noted that the determination of the
kinetic parameters of ATP and ADP inhibition of
ecto-58-nucleotidase is subject to an error due to the
metabolism of ATP and ADP during the determination
of the initial rates of ecto-58-nucleotidase. However, it
can be excluded that the competitive inhibition of
ecto-58-nucleotidase by ATP and ADP might be due to
AMP formation during the initial rate determinations,
since the Ki of AMP as inhibitor of the extracellular
catabolism of IMP is higher (Ki 5 68–104 mM, n 5 2)
(data not shown).
Comparison of ‘Ecto-ATPase’, ‘Ecto-ADPase’ and
Ecto-59-Nucleotidase Specific Activities in Hippocam-
pal Nerve Terminals. It is interesting to note that the
values obtained for the Ki of ATP and ADP [14 mM and
4 mM, similar to the Ki values obtained for these com-
pounds as ecto-58-nucleotidase inhibitors, as reviewed
in (56)] are in very good agreement with the threshold
concentration of ATP and ADP required to relieve
extracellular adenosine formation in rat hippocampal
nerve terminals (5 mM). This suggests that a near 50%
inhibition of ecto-58-nucleotidase has a profound effect
on the pattern of ATP-derived adenosine formation.
This is only expectable if ecto-58-nucleotidase is the en-
zyme with the lower activity in the pathway (i.e. ‘rate-
limiting step’). To test this prediction, the specific
activity of the extracellular catabolism of ATP, ADP
and AMP was compared in rat hippocampal nerve
terminals. As illustrated in Table I the specific activity
of ‘ecto-ATPase’ and ‘ecto-ADPase’ is more than
20–25 times higher than the specific activity of ecto-
58-nucleotidase (please keep in mind that this nomen-
clature does not imply the understanding of any
particular molecular form of any of these enzymes).
The data shown in Table I were obtained with initial
concentration of ATP, ADP and AMP of 10 mM, but
the relation between the specific activities of extracel-
lular catabolism of ATP, ADP and AMP was observed
at initial substrate concentrations of 3 mM and 100 mM
(n 5 3–6).
The relation between ecto-nucleotidases activities
appears to change in different preparations (reviewed
in 40). Indeed, the ratio of extracellular catabolism of
ATP:ADP:AMP was also high (from 40:30:1 to 60:
20:10) in striatal cholinergic nerve terminals (24), cul-
tured rat brain astrocytes (58) or in chromaffin cells
(59), but was lower (from 4:3:1 to 2:1:1) in other prepa-
rations such as Torpedo nerve terminals (60) or rat cor-
tical nerve terminals (61), Thus, it can be concluded
that the relative density of each ecto-nucleotidase activ-
ity changes between tissues, as indicated by the nearly
2-fold spread in the specific activities of ecto-ATPases
(33,45,61) and ecto-58-nucleotidases (see references in
56) between preparations.
Extracellular ATP Catabolism in Hippocampal
Cholinergic Nerve Terminals. It was previously de-
scribed that ecto-58-nucleotidase was enriched in
hippocampal cholinergic nerve terminals (35). It was
now tested if ‘ecto-ATPase’ was also enriched in hip-
pocampal cholinergic nerve terminals by comparing
the initial rate of extracellular catabolism of ATP, nor-
malised by mg of protein, in whole hippocampal nerve
terminals and in immunopurified cholinergic nerve
terminals. The specific activity of extracellular catab-
olism of ATP (10 mM) in hippocampal cholinergic
nerve terminals (measured during the initial 5 min
of catabolism using 2.2–4.6 mg protein) was 146 6
11 nmol/min/mg protein (n 5 6), revealing a 5-fold
enrichment when compared with the specific activity
of extracellular catabolism of ATP (10 mM) in whole
hippocampal nerve terminals (measured during the
first 2.5 min of catabolism using 72–104 mg protein),
which was 27.5 6 0.9 nmol/min/mg protein (n 5 3).
As was done with whole hippocampal nerve ter-
minals, it was also tested if b,g-imido ATP (100 mM)
displayed a different efficiency to inhibit extracellular
ATP and ADP catabolism in immunopurified choliner-
gic nerve terminals. As illustrated in Fig. 6, b,g-imido
ATP (100 mM) caused a similar inhibition of ATP and
ADP catabolism (n 5 3). Thus, in contrast to what was
concluded in whole hippocampal nerve terminals (cf.
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Table I. Comparison of the Specific Rate of Extracellular
Catabolism of ATP, ADP, and AMP in Rat Hippocampal
Nerve Terminals
Specific activity (nmol/min/mg protein)
ATP hydrolysis (n 5 3) 27.5 6 0.9
ADP hydrolysis (n 5 5) 18.4 6 0.3
AMP hydrolysis (n 5 5) 0.78 6 0.05
ATP, ADP or AMP (10 mM) was added at zero time to rat hip-
pocampal nerve terminals (87–145 mg protein) and samples were
collected from the bath at 0, 0.5, 1, 1.5, 2, 3 and 5 min. Each col-
lected sample was analysed by HPLC to separate and quantify ATP
and its metabolites. The initial rates were calculated by fitting the
initial decrease of concentration of the initially added substrate, and
the specific activity was then normalised by the amount of protein
in the assay. The presented specific activities are the mean 6 sem
of the n experiments.
Fig. 2), it appears that in cholinergic nerve terminals
the major enzymatic activity responsible for ATP
catabolism might be an ecto-ATP diphosphohydrolase.
It should also be added that b,g-imido ATP (100 mM)
was not catabolised, in a measurable manner, in cholin-
ergic nerve terminals, indicating an apparent lack of an
ecto-nucleotide pyrophosphatase activity.
Different Pattern of Adenosine Formation Ac-
cording to the Initial Concentration of ATP in Rat
Hippocampal Cholinergic Nerve Terminals. In Fig. 7
is shown the time-course kinetic of purines metabo-
lites identified upon addition of different initial con-
centrations of ATP (3 mM, 10 mM and 100 mM). This
is one out of 4 similar experiments where the three
concentrations of ATP were tested in the same batch
of nerve terminals. It can be concluded from Fig. 7 that
the pattern of ATP catabolism is qualitatively similar
to that observed for whole hippocampal nerve termi-
nals (cf. Fig. 1). However, there are quantitative dif-
ferences mostly in relation to the pattern of AMP and
adenosine formation. Thus, in contrast to whole hip-
pocampal nerve terminals, in cholinergic nerve termi-
nals, there is not an accumulation of AMP as the initial
concentration of ATP is increased. The maximal peak
of AMP concentration is reached at similar time points
after addition of different initial concentrations of
ATP (12.4 6 0.7 min with 3 mM ATP, 12.8 6 0.8 min
with 10 mM ATP and 13.1 6 0.9 min with 30 mM
ATP). Also, the percentage of the maximal concen-
tration of AMP in relation to the initial concentration
of ATP is similar (28% with 3 mM ATP, 26% with
10 mM ATP and 21% with 30 mM ATP).
In relation to adenosine formation, the data shown
in Fig. 7 clearly indicate the lack of appearance of a
delayed burst-like formation of adenosine as the initial
concentration of ATP is increased. The rate of forma-
tion of extracellular adenosine is similar throughout
the time course kinetic experiments, irrespective of the
initial concentration of added ATP. This maintenance
of the patterns of AMP and adenosine formation at dif-
ferent concentrations of initially added ATP in cholin-
ergic nerve terminals, in contrast to what occurred in
whole nerve terminals, cannot be attributed to the use
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Fig. 6. Inhibition by b,g-imido ATP of ATP and ADP extracellular
catabolism in rat hippocampal cholinergic nerve terminals. ATP
(10 mM; u,j) or ADP (10 mM; s,d) was added at zero time to rat
hippocampal nerve terminals (2.2–4.3 mg protein) in the absence
(open symbols) or in the presence (filled symbols) of b,g-imido ATP
(b,g-ImATP, 100 mM) and samples were collected from the bath at
the times indicated in the abscissa. Each collected sample was
analysed by ion-pair reverse-phase HPLC (Cunha et al., 1998) to
quantify ATP and ADP. The data are mean 6 sem of 3 experiments.
Fig. 7. Different time course kinetic pattern of ATP metabolism in
rat hippocampal cholinergic nerve terminals with different con-
centrations of extracellularly added ATP. ATP (3 mM in A; 10 mM
in B; and 30 mM in C) was added at zero time to rat hippocampal
immunopurified cholinergic nerve terminals (2.8 mg protein) and
samples were collected from the bath at the times indicated in the
abscissa. Each collected sample was analysed by HPLC to separate
and quantify ATP (j) and its metabolites, ADP (d), AMP (.) and
adenosine (s). The data were obtained from a single experiment
representative of 4 similar experiments.
of different amounts of protein in each of the assays.
In time course kinetic studies, changing the amount of
protein in the assay only changes the temporal pattern
of variation of the pathway metabolites, not the rela-
tion between the pattern of formation between each of
them. Thus, this maintenance of AMP and adenosine
formation at different concentrations of initially added
ATP is indicative of a lack of effective feed-forward
inhibition of ecto-58-nucleotidase by ATP and ADP in
cholinergic nerve terminals.
This could possibly be a consequence of the much
higher relative enrichment in ecto-58-nucleotidase (42-
fold) than of ‘ecto-ATPase’ (5-fold) when immunopuri-
fying the cholinergic nerve terminals, so that it would
require a much more profound inhibition of ecto-58-
nucleotidase to be able to make this step rate-limiting in
the ecto-nucleotidase cascade. Alternatively, one can
argue that there is a channelling organization between
ATP/ADP catabolism and ecto-58-nucleotidase. This
would match the observation that the extracellular con-
centration of AMP in the bio-phase does not increase,
as would be predicted based on the amounts of ADP
metabolised, and there is a proportionally larger forma-
tion of the product of the channelling process, adeno-
sine. This possible channelling organisation would be in
accordance with the existence of a feed-forward inhibi-
tion of ecto-58-nucleotidase by ATP and ADP that
would not have an appreciable impact on the flow
through the entire pathway.
CONCLUDING REMARKS
The data presented in this work indicate that the
regulation of adenosine production from released ATP
is different in different nerve terminals populations.
Indeed, in whole hippocampal nerve terminals, there is
a dominant feed-forward inhibition of ecto-58-nucleo-
tidase that initially decreases the efficiency of adeno-
sine formation, but, once the levels of ATP 1 ADP
decrease below the threshold of inhibition of ecto-58-
nucleotidase, there is a delayed burst-like formation of
adenosine. In contrast, in hippocampal cholinergic
nerve terminals, the preferential delivery of AMP to
ecto-58-nucleotidase outweighs feed-forward inhibition
of ecto-58-nucleotidase and the net effect is a rapid and
near-linear formation of adenosine irrespective of the
extracellular concentration of ATP.
This pattern of extracellular ATP-derived adeno-
sine formation might be dependent on the balance be-
tween the two modes of control of ecto-58-nucleotidase
activity: feed-forward inhibition by ATP/ADP and
channelling of AMP to ecto-58-nucleotidase. Feed-
forward inhibition of ecto-58-nucleotidase allows to re-
late the pattern of adenosine formation to the amounts
of released ATP, and the amounts of released ATP in
glutamatergic synapses of the hippocampus are expo-
nentially related to the frequency of firing (5,6). Thus,
when low amounts of ATP are released, one expects the
rapid activation of A1 receptors to refrain excessive
presynaptic facilitation (34,62,63). However, high fre-
quencies of stimulation of hippocampal glutamatergic
circuits trigger synaptic plasticity phenomena (64). In
these high-frequency stimulation conditions, extracellu-
lar adenosine is mostly formed by the ecto-nucleotidase
pathway from the massive amounts of released ATP
(5,34). The levels of adenosine reached extracellularly,
if directed to A1 receptor activation, would be enough
to nearly block synaptic transmission (34), and adeno-
sine would fulfil a role opposite to that required in a sit-
uation of activity-dependent facilitation. It is precisely
in this situation that the feed-forward inhibition of ecto-
58-nucleotidase by the high amounts of ATP released
will cause a delay in adenosine formation thus over-
coming immediate A1 receptor activation. Furthermore,
the delayed formation of large amounts of adenosine
may favour A2A receptor activation (19). Thus, adeno-
sine would be fulfilling a role in accordance with the
physiological needs, i.e. to contribute for facilitation of
synaptic transmission, possibly through an A2A recep-
tor-induced A1 receptor desensitisation (65). As previ-
ously discussed, the effect of changing the amount of
enzyme in a time course kinetic assay is to distend or
contract the x-axis (66). In synapses, ATP may be re-
leased in high concentrations (see 18) mostly because
of the small volume of the synaptic cleft. But this re-
leased ATP faces high densities of ecto-nucleotidases
(the same enzymatic densities as these measured in the
600 ml assays in the present study). Thus, it is expected
that the burst-like formation of adenosine may occur
much faster than observed in the present in vitro as-
says, making this controlled ATP-derived extracellular
adenosine potentially more relevant for synaptic plas-
ticity phenomena that occur in a millisecond rather than
in a minute scale.
The situation is different in hippocampal cholinergic
nerve terminals where preferential AMP delivery to ecto-
58-nucleotidase causes a near-linear formation of ATP-
derived adenosine. In such conditions, one does not
expect a delay in adenosine formation, nor a burst-like
formation of adenosine. Thus, the kinetic characteristics
of the ecto-nucleotidase pathway would mainly conduct
to an A1 receptor-mediated inhibition of acetylcholine re-
lease over a wide range of frequency stimulation. This
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might not be inadequate in this preparation, since I am
not aware of long-term plasticity in cholinergic synapses,
only short-term plasticity phenomena (67). Interestingly,
it is precisely in cholinergic synapses that inhibition of
ecto-58-nucleotidase blunts tonic A1 rather than A2A re-
ceptor activation (29,31,32). And, according to Redman
and Silinsky (31), the channelling properties of the ecto-
nucleotidase pathway at the level of ecto-58-nucleotidase
would be ideally suited to relate the activity-dependent
ATP release (3) with a short-term frequency-dependent
depression of neuromuscular transmission (Wedinski’s
inhibition). Acetylcholine release from hippocampal
nerve terminals is controlled both by A1 and A2A recep-
tors (68), and endogenous adenosine can activate both
A1 and A2A receptors (69,70). It is evident that, in con-
trast to glutamatergic synapses, the ecto-nucleotidase
pathway that equips cholinergic nerve terminals is not
endowed with kinetic characteristics to select A2A versus
A1 receptor activation. Other, still undetermined factors
may be responsible for determining A1/A2A receptor-
mediated control of acetylcholine release. In this respect,
an elegant study has shown that A2A receptor facilitation
of acetylcholine release from hippocampal slices occur at
endogenous extracellular concentrations of adenosine
lower than these required to activate A1 receptors (70),
indicating that the intrinsic efficiency of A1/A2A receptors
is different in cholinergic and glutamatergic synapses.
In summary, the present work provides evidences
for different patterns of regulation of extracellular
ATP-derived adenosine formation that provide a logi-
cal candidate explanation for the different roles of
ATP-derived adenosine in the control of glutamatergic
and cholinergic synapses in the hippocampus. How-
ever, it should be stressed that this study was only car-
ried in nerve terminal preparations and one needs to
know the relative contribution for extracellular adeno-
sine formation of postsynaptic components and of glial
cells to understand the relation between adenosine
formation and neuromodulation at a synapse. Also, the
example of hippocampal cholinergic nerve terminals
makes it clear that the characteristics of the ecto-
nucleotidase pathway are only one of the variables
involved in the control of adenosine modulation of
neurotransmitter release, as previously discussed (14).
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